がん光線力学療法の世界市場インサイト・予測(~2028年)

調査会社QYResearch社が発行したリサーチレポート(データ管理コード:QY22JL3467)
■ 英語タイトル:Global Cancer Photodynamic Therapy Market Insights, Forecast to 2028
■ 発行会社/調査会社:QYResearch
■ 商品コード:QY22JL3467
■ 発行日:2022年7月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:109
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[がん光線力学療法の世界市場インサイト・予測(~2028年)]についてメールでお問い合わせはこちら
COVID-19のパンデミックにより、がん光線力学療法のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にがん光線力学療法の世界市場のxxx%を占める「デバイス」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「癌腫」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
がん光線力学療法の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのがん光線力学療法市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

がん光線力学療法のグローバル主要企業には、Sanofi、DUSA Pharmaceuticals、Bausch Health、Beiersdorf、Soligenix、Theralase Technologies、Quest Pharmatech、Galderma、Biofrontera、Lumenis、PhotoMedex、Biolitec、Ambicare Healthなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

がん光線力学療法市場は、種類と用途によって区分されます。世界のがん光線力学療法市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
デバイス、薬物

【用途別セグメント】
癌腫、肉腫、黒色腫、リンパ腫、白血病

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- がん光線力学療法製品概要
- 種類別市場(デバイス、薬物)
- 用途別市場(癌腫、肉腫、黒色腫、リンパ腫、白血病)
- 調査の目的
・エグゼクティブサマリー
- 世界のがん光線力学療法販売量予測2017-2028
- 世界のがん光線力学療法売上予測2017-2028
- がん光線力学療法の地域別販売量
- がん光線力学療法の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別がん光線力学療法販売量
- 主要メーカー別がん光線力学療法売上
- 主要メーカー別がん光線力学療法価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(デバイス、薬物)
- がん光線力学療法の種類別販売量
- がん光線力学療法の種類別売上
- がん光線力学療法の種類別価格
・用途別市場規模(癌腫、肉腫、黒色腫、リンパ腫、白血病)
- がん光線力学療法の用途別販売量
- がん光線力学療法の用途別売上
- がん光線力学療法の用途別価格
・北米市場
- 北米のがん光線力学療法市場規模(種類別、用途別)
- 主要国別のがん光線力学療法市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのがん光線力学療法市場規模(種類別、用途別)
- 主要国別のがん光線力学療法市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のがん光線力学療法市場規模(種類別、用途別)
- 主要国別のがん光線力学療法市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のがん光線力学療法市場規模(種類別、用途別)
- 主要国別のがん光線力学療法市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのがん光線力学療法市場規模(種類別、用途別)
- 主要国別のがん光線力学療法市場規模(トルコ、サウジアラビア)
・企業情報
Sanofi、DUSA Pharmaceuticals、Bausch Health、Beiersdorf、Soligenix、Theralase Technologies、Quest Pharmatech、Galderma、Biofrontera、Lumenis、PhotoMedex、Biolitec、Ambicare Health
・産業チェーン及び販売チャネル分析
- がん光線力学療法の産業チェーン分析
- がん光線力学療法の原材料
- がん光線力学療法の生産プロセス
- がん光線力学療法の販売及びマーケティング
- がん光線力学療法の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- がん光線力学療法の産業動向
- がん光線力学療法のマーケットドライバー
- がん光線力学療法の課題
- がん光線力学療法の阻害要因
・主な調査結果
*** レポート概要(サマリー)***

Market Analysis and Insights: Global Cancer Photodynamic Therapy Market
The global Cancer Photodynamic Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Device accounting for % of the Cancer Photodynamic Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Carcinoma segment is altered to an % CAGR throughout this forecast period.
China Cancer Photodynamic Therapy market size is valued at US$ million in 2021, while the North America and Europe Cancer Photodynamic Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cancer Photodynamic Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Photodynamic Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Photodynamic Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Photodynamic Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Photodynamic Therapy market.
Global Cancer Photodynamic Therapy Scope and Market Size
Cancer Photodynamic Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Photodynamic Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Device
Drug
Segment by Application
Carcinoma
Sarcoma
Melanoma
Lymphoma
Leukemia
By Company
Sanofi
DUSA Pharmaceuticals
Bausch Health
Beiersdorf
Soligenix
Theralase Technologies
Quest Pharmatech
Galderma
Biofrontera
Lumenis
PhotoMedex
Biolitec
Ambicare Health
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

*** レポート目次(コンテンツ)***

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Photodynamic Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Device
1.2.3 Drug
1.3 Market by Application
1.3.1 Global Cancer Photodynamic Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Carcinoma
1.3.3 Sarcoma
1.3.4 Melanoma
1.3.5 Lymphoma
1.3.6 Leukemia
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Photodynamic Therapy Market Perspective (2017-2028)
2.2 Cancer Photodynamic Therapy Growth Trends by Region
2.2.1 Cancer Photodynamic Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Photodynamic Therapy Historic Market Size by Region (2017-2022)
2.2.3 Cancer Photodynamic Therapy Forecasted Market Size by Region (2023-2028)
2.3 Cancer Photodynamic Therapy Market Dynamics
2.3.1 Cancer Photodynamic Therapy Industry Trends
2.3.2 Cancer Photodynamic Therapy Market Drivers
2.3.3 Cancer Photodynamic Therapy Market Challenges
2.3.4 Cancer Photodynamic Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Photodynamic Therapy Players by Revenue
3.1.1 Global Top Cancer Photodynamic Therapy Players by Revenue (2017-2022)
3.1.2 Global Cancer Photodynamic Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Photodynamic Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Photodynamic Therapy Revenue
3.4 Global Cancer Photodynamic Therapy Market Concentration Ratio
3.4.1 Global Cancer Photodynamic Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Photodynamic Therapy Revenue in 2021
3.5 Cancer Photodynamic Therapy Key Players Head office and Area Served
3.6 Key Players Cancer Photodynamic Therapy Product Solution and Service
3.7 Date of Enter into Cancer Photodynamic Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Photodynamic Therapy Breakdown Data by Type
4.1 Global Cancer Photodynamic Therapy Historic Market Size by Type (2017-2022)
4.2 Global Cancer Photodynamic Therapy Forecasted Market Size by Type (2023-2028)
5 Cancer Photodynamic Therapy Breakdown Data by Application
5.1 Global Cancer Photodynamic Therapy Historic Market Size by Application (2017-2022)
5.2 Global Cancer Photodynamic Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Photodynamic Therapy Market Size (2017-2028)
6.2 North America Cancer Photodynamic Therapy Market Size by Type
6.2.1 North America Cancer Photodynamic Therapy Market Size by Type (2017-2022)
6.2.2 North America Cancer Photodynamic Therapy Market Size by Type (2023-2028)
6.2.3 North America Cancer Photodynamic Therapy Market Share by Type (2017-2028)
6.3 North America Cancer Photodynamic Therapy Market Size by Application
6.3.1 North America Cancer Photodynamic Therapy Market Size by Application (2017-2022)
6.3.2 North America Cancer Photodynamic Therapy Market Size by Application (2023-2028)
6.3.3 North America Cancer Photodynamic Therapy Market Share by Application (2017-2028)
6.4 North America Cancer Photodynamic Therapy Market Size by Country
6.4.1 North America Cancer Photodynamic Therapy Market Size by Country (2017-2022)
6.4.2 North America Cancer Photodynamic Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cancer Photodynamic Therapy Market Size (2017-2028)
7.2 Europe Cancer Photodynamic Therapy Market Size by Type
7.2.1 Europe Cancer Photodynamic Therapy Market Size by Type (2017-2022)
7.2.2 Europe Cancer Photodynamic Therapy Market Size by Type (2023-2028)
7.2.3 Europe Cancer Photodynamic Therapy Market Share by Type (2017-2028)
7.3 Europe Cancer Photodynamic Therapy Market Size by Application
7.3.1 Europe Cancer Photodynamic Therapy Market Size by Application (2017-2022)
7.3.2 Europe Cancer Photodynamic Therapy Market Size by Application (2023-2028)
7.3.3 Europe Cancer Photodynamic Therapy Market Share by Application (2017-2028)
7.4 Europe Cancer Photodynamic Therapy Market Size by Country
7.4.1 Europe Cancer Photodynamic Therapy Market Size by Country (2017-2022)
7.4.2 Europe Cancer Photodynamic Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Photodynamic Therapy Market Size (2017-2028)
8.2 Asia-Pacific Cancer Photodynamic Therapy Market Size by Type
8.2.1 Asia-Pacific Cancer Photodynamic Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cancer Photodynamic Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cancer Photodynamic Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Cancer Photodynamic Therapy Market Size by Application
8.3.1 Asia-Pacific Cancer Photodynamic Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cancer Photodynamic Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cancer Photodynamic Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Cancer Photodynamic Therapy Market Size by Region
8.4.1 Asia-Pacific Cancer Photodynamic Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cancer Photodynamic Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Photodynamic Therapy Market Size (2017-2028)
9.2 Latin America Cancer Photodynamic Therapy Market Size by Type
9.2.1 Latin America Cancer Photodynamic Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Cancer Photodynamic Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Cancer Photodynamic Therapy Market Share by Type (2017-2028)
9.3 Latin America Cancer Photodynamic Therapy Market Size by Application
9.3.1 Latin America Cancer Photodynamic Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Cancer Photodynamic Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Cancer Photodynamic Therapy Market Share by Application (2017-2028)
9.4 Latin America Cancer Photodynamic Therapy Market Size by Country
9.4.1 Latin America Cancer Photodynamic Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Cancer Photodynamic Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Photodynamic Therapy Market Size (2017-2028)
10.2 Middle East & Africa Cancer Photodynamic Therapy Market Size by Type
10.2.1 Middle East & Africa Cancer Photodynamic Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cancer Photodynamic Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cancer Photodynamic Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Cancer Photodynamic Therapy Market Size by Application
10.3.1 Middle East & Africa Cancer Photodynamic Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cancer Photodynamic Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cancer Photodynamic Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Cancer Photodynamic Therapy Market Size by Country
10.4.1 Middle East & Africa Cancer Photodynamic Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cancer Photodynamic Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Cancer Photodynamic Therapy Introduction
11.1.4 Sanofi Revenue in Cancer Photodynamic Therapy Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 DUSA Pharmaceuticals
11.2.1 DUSA Pharmaceuticals Company Details
11.2.2 DUSA Pharmaceuticals Business Overview
11.2.3 DUSA Pharmaceuticals Cancer Photodynamic Therapy Introduction
11.2.4 DUSA Pharmaceuticals Revenue in Cancer Photodynamic Therapy Business (2017-2022)
11.2.5 DUSA Pharmaceuticals Recent Developments
11.3 Bausch Health
11.3.1 Bausch Health Company Details
11.3.2 Bausch Health Business Overview
11.3.3 Bausch Health Cancer Photodynamic Therapy Introduction
11.3.4 Bausch Health Revenue in Cancer Photodynamic Therapy Business (2017-2022)
11.3.5 Bausch Health Recent Developments
11.4 Beiersdorf
11.4.1 Beiersdorf Company Details
11.4.2 Beiersdorf Business Overview
11.4.3 Beiersdorf Cancer Photodynamic Therapy Introduction
11.4.4 Beiersdorf Revenue in Cancer Photodynamic Therapy Business (2017-2022)
11.4.5 Beiersdorf Recent Developments
11.5 Soligenix
11.5.1 Soligenix Company Details
11.5.2 Soligenix Business Overview
11.5.3 Soligenix Cancer Photodynamic Therapy Introduction
11.5.4 Soligenix Revenue in Cancer Photodynamic Therapy Business (2017-2022)
11.5.5 Soligenix Recent Developments
11.6 Theralase Technologies
11.6.1 Theralase Technologies Company Details
11.6.2 Theralase Technologies Business Overview
11.6.3 Theralase Technologies Cancer Photodynamic Therapy Introduction
11.6.4 Theralase Technologies Revenue in Cancer Photodynamic Therapy Business (2017-2022)
11.6.5 Theralase Technologies Recent Developments
11.7 Quest Pharmatech
11.7.1 Quest Pharmatech Company Details
11.7.2 Quest Pharmatech Business Overview
11.7.3 Quest Pharmatech Cancer Photodynamic Therapy Introduction
11.7.4 Quest Pharmatech Revenue in Cancer Photodynamic Therapy Business (2017-2022)
11.7.5 Quest Pharmatech Recent Developments
11.8 Galderma
11.8.1 Galderma Company Details
11.8.2 Galderma Business Overview
11.8.3 Galderma Cancer Photodynamic Therapy Introduction
11.8.4 Galderma Revenue in Cancer Photodynamic Therapy Business (2017-2022)
11.8.5 Galderma Recent Developments
11.9 Biofrontera
11.9.1 Biofrontera Company Details
11.9.2 Biofrontera Business Overview
11.9.3 Biofrontera Cancer Photodynamic Therapy Introduction
11.9.4 Biofrontera Revenue in Cancer Photodynamic Therapy Business (2017-2022)
11.9.5 Biofrontera Recent Developments
11.10 Lumenis
11.10.1 Lumenis Company Details
11.10.2 Lumenis Business Overview
11.10.3 Lumenis Cancer Photodynamic Therapy Introduction
11.10.4 Lumenis Revenue in Cancer Photodynamic Therapy Business (2017-2022)
11.10.5 Lumenis Recent Developments
11.11 PhotoMedex
11.11.1 PhotoMedex Company Details
11.11.2 PhotoMedex Business Overview
11.11.3 PhotoMedex Cancer Photodynamic Therapy Introduction
11.11.4 PhotoMedex Revenue in Cancer Photodynamic Therapy Business (2017-2022)
11.11.5 PhotoMedex Recent Developments
11.12 Biolitec
11.12.1 Biolitec Company Details
11.12.2 Biolitec Business Overview
11.12.3 Biolitec Cancer Photodynamic Therapy Introduction
11.12.4 Biolitec Revenue in Cancer Photodynamic Therapy Business (2017-2022)
11.12.5 Biolitec Recent Developments
11.13 Ambicare Health
11.13.1 Ambicare Health Company Details
11.13.2 Ambicare Health Business Overview
11.13.3 Ambicare Health Cancer Photodynamic Therapy Introduction
11.13.4 Ambicare Health Revenue in Cancer Photodynamic Therapy Business (2017-2022)
11.13.5 Ambicare Health Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(QY22JL3467 )"がん光線力学療法の世界市場インサイト・予測(~2028年)" (英文:Global Cancer Photodynamic Therapy Market Insights, Forecast to 2028)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。